These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 654230)

  • 1. [Pancreatic exocrine secretion in cancer of the pancreas].
    Mendizova A
    Vutr Boles; 1978; 17(2):18-24. PubMed ID: 654230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in salivary secretion in pancreatic patients].
    Mendizova A; Ivanov L
    Vutr Boles; 1981; 20(5):21-7. PubMed ID: 7324450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of alcohol on pancreatic exocrine secretion].
    Mendizova A; Glavincheva I
    Vutr Boles; 1979; 18(6):28-32. PubMed ID: 524870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic exocrine secretion in chronic alcoholism].
    Mendizova A
    Vutr Boles; 1981; 20(4):18-24. PubMed ID: 7303636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon inhibition of secretin and combined secretin and cholecystokinin stimulated pancreatic exocrine secretion in health and disease.
    Clain JE; Barbezat GO; Waterworth MM; Bank S
    Digestion; 1978; 17(1):11-7. PubMed ID: 627317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effects of natural and synthetic secretin on the exocrine secretion of the human pancreas (author's transl)].
    Hoppe B; Fritsch WP; Scholten T; Rick W; Strohmeyer G
    Z Gastroenterol; 1980 Dec; 18(12):625-32. PubMed ID: 7281853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative functional, scintigraphic and angiographic studies in pancreatic diseases].
    Mendizova A; Brailski Kh; Bozhiianov V; Romanova A; Merdzhanov A
    Vutr Boles; 1979; 18(2):27-37. PubMed ID: 462933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of pancreatic cancer by endoscopic retrograde cholangiopancreatography and pancreozymin secretin test.
    Nakano S; Takeda I; Watahiki H; Nakamura M
    Gastroenterol Jpn; 1977; 12(4):263-8. PubMed ID: 590698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic exocrine secretion in patients with cirrhosis of the liver (author's transl)].
    Brailski C; Mendisova A; Glawintschewa I
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(5):213-9. PubMed ID: 6173189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the tests used in the diagnosis of pancreatic diseases].
    Lenti G; Emanuelli G
    Minerva Med; 1976 Nov; 67(55):3661-70. PubMed ID: 995311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exocrine pancreatic secretion changes associated with age.
    Dreiling DA; Triebling AT; Koller M
    Mater Med Pol; 1991; 23(1):17-9. PubMed ID: 1843971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationships between pancreatic ductal obstruction and pancreatic secretion in man.
    DiMagno EP; Malagelada JR; Go VL
    Mayo Clin Proc; 1979 Mar; 54(3):157-62. PubMed ID: 431121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal control of exocrine pancreatic secretion in the isolated intact rat pancreas.
    Camello PJ; Wisdom DM; Singh J; Salido GM
    Rev Esp Fisiol; 1994 Mar; 50(1):35-40. PubMed ID: 7991937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of secretin-stimulated exocrine pancreatic secretion by diazoxide in the rat.
    Pedrazzoli S; Dodi G; Militello C; Favretti F; Brandstetter S; Lise M
    Eur Surg Res; 1978; 10(1):33-9. PubMed ID: 631147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of neurotensin, cholecystokinin, and secretin in the stimulation of the exocrine pancreas in the dog.
    Baća I; Feurle GE; Haas M; Mernitz T
    Gastroenterology; 1983 Mar; 84(3):556-61. PubMed ID: 6295872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
    Lembcke B; Konle O; Duan LP; Caspary WF
    Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.
    Friess H; Kleeff J; Malfertheiner P; Müller MW; Homuth K; Büchler MW
    Int J Pancreatol; 1998 Apr; 23(2):115-23. PubMed ID: 9629509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical importance of the secretin-pancreozymin test in the diagnosis of chronic and neoplastic exocrine pancreatopathies].
    Taschieri AM; Pucci C; Scortecci V; Trivellini G
    Arch Ital Chir; 1967; 93(1):697-713. PubMed ID: 5621876
    [No Abstract]   [Full Text] [Related]  

  • 19. Action of pancreatic polypeptide on exocrine pancreas and on release of cholecystokinin and secretin.
    Lonovics J; Guzman S; Devitt PG; Hejtmancik KE; Suddith RL; Rayford PL; Thompson JC
    Endocrinology; 1981 May; 108(5):1925-30. PubMed ID: 7215307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].
    Creutzfeldt W; Lankisch PG; Fölsch UR
    Dtsch Med Wochenschr; 1975 May; 100(20):1135-8. PubMed ID: 1126301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.